logo
Select company
Select metric
-127689.7%EBITDA Margin
VS
Market
0
Sector
1
Industry
1
History
20
$ 3.49Close
$ 2.59 - $ 5.73 52-Week Range
Ticker Information

Ticker

HSCS

Company Name

HEARTSCIENCES INC

Sector

Healthcare

Industry

Medical Devices

Exchange

NASDAQ

HEARTSCIENCES INC - EBITDA Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

HSCS - EBITDA % Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA MarginRevenues
6/30/2025$ -7.98M-127689.7%$ 6.25K
3/31/2025$ -8.14M-187053.33%$ 4.35K
12/31/2024$ -8M0%$ 0
9/30/2024$ -7.2M-48960.47%$ 14.7K
6/30/2024$ -6.83M-36712.81%$ 18.6K
3/31/2024$ -6.16M-33096.75%$ 18.6K
12/31/2023$ -6M-32251.55%$ 18.6K
9/30/2023$ -5.78M-98796.32%$ 5.85K
6/30/2023$ -5.98M-306880.72%$ 1.95K
3/31/2023$ -6.08M-118139.83%$ 5.15K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • HEARTSCIENCES INC's latest trailing twelve months (TTM) EBITDA % stands at -30822.2%.
  • Over the past 5 years, HEARTSCIENCES INC's average EBITDA % has been -99081.59%.
  • The median EBITDA % for HEARTSCIENCES INC during this period was -69493.81%
  • HEARTSCIENCES INC reached its highest EBITDA % over the past 5 years at -30822.2%.
  • The lowest EBITDA % recorded by HEARTSCIENCES INC in the same timeframe -306880.72%

HEARTSCIENCES INC's EBITDA % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA % Benchmarks
CompanyEBITDA %
CELZ : CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC -94206.33%IBO : IMPACT BIOMEDICAL INC -517200%AMIX : AUTONOMIX MEDICAL INC -TCRT : ALAUNOS THERAPEUTICS INC -99850%OSRH : OSR HOLDINGS INC -363.64%BBLG : BONE BIOLOGICS CORP -ADIL : ADIAL PHARMACEUTICALS INC -DWTX : DOGWOOD THERAPEUTICS INC -AEMD : AETHLON MEDICAL INC -RNAZ : TRANSCODE THERAPEUTICS INC -

Definition of EBITDA Margin

[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
EBITDA / Revenues
(=) EBITDA %
EBITDA % for HEARTSCIENCES INC is calculated as follows: EBITDA [ $ -4.43M ] / Revenues [ $ 14.37K ]
(=) EBITDA % [ -30822.2% ]

HSCS - EBITDA Margin, Last 5 years

-306880.72%

Minimum

Jun 30, 2023

-30822.2%

Maximum

Mar 31, 2022

-99081.59%

Average

-69493.81%

Median

EBITDA % Benchmark Analysis

The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.2% with a standard deviation of 26.73%.
The following table provides additional summary stats:
EBITDA % in the Market:
filtered constituents3.29K
min-74.33%
max97.24%
average16.2%
median14.74%
std26.73%